Table 3. FPRP values for associations between the risk of cancer and the frequency of genotypes.

Comparison	Subgroup	n	PZ	OR (95% CI)	Statistical power
						0.25	0.1	0.01	0.001
(-196 to -174del)
B vs. A	Overall	18	0.005*	1.468 (1.129–1.91)	0.564	0.022†	0.064†	0.427	0.883
BB vs. AA	Overall	18	0.005*	1.716 (1.178–2.5)	0.237	0.054†	0.146†	0.652	0.950
BA vs. AA	Overall	18	0.008*	1.408 (1.092–1.816)	0.683	0.035†	0.099†	0.547	0.924
BB+BA vs. AA	Overall	18	0.007*	1.449 (1.107–1.897)	0.597	0.034†	0.096†	0.539	0.922
BB vs. BA+ AA	Overall	18	0.013*	1.517 (1.092–2.107)	0.468	0.073†	0.192†	0.723	0.963
B vs. A	Asian	11	0.043*	1.169 (1.005–1.361)	0.999	0.117†	0.285	0.814	0.978
BB+BA vs. AA	Asian	11	0.033*	1.203 (1.015–1.427)	0.994	0.106†	0.262	0.796	0.975
B vs. A	Caucasian	3	0.028*	3.291 (1.139–9.51)	0.073	0.532	0.773	0.974	0.997
BB vs. AA	Caucasian	3	0.008*	9.878 (1.83–53.322)	0.014	0.621	0.831	0.982	0.998
BA vs. AA	Caucasian	3	0.044*	3.156 (1.034–9.634)	0.096	0.577	0.804	0.978	0.998
BB+BA vs. AA	Caucasian	3	0.034*	3.555 (1.098–11.51)	0.075	0.579	0.805	0.978	0.998
BB vs. BA+ AA	Caucasian	3	0.006*	7.294 (1.752–30.369)	0.015	0.561	0.793	0.977	0.998
B vs. A	PB	14	0.001*	1.576 (1.193–2.08)	0.364	0.011†	0.031†	0.263	0.783
BB vs. AA	PB	14	0.001*	2.274 (1.43–3.616)	0.040	0.039†	0.108†	0.571	0.931
BA vs. AA	PB	14	0.005*	1.543 (1.143–2.081)	0.427	0.031†	0.086†	0.510	0.913
BB+BA vs. AA	PB	14	0.002*	1.624 (1.186–2.223)	0.310	0.023†	0.067†	0.441	0.888
BB vs. BA+ AA	PB	14	0.001*	2.011 (1.317–3.07)	0.087	0.040†	0.111†	0.578	0.933
B vs. A	Y	15	0.008*	1.447 (1.103–1.897)	0.603	0.036†	0.101†	0.551	0.925
BB vs. AA	Y	15	0.004*	1.915 (1.227–2.991)	0.141	0.083†	0.214	0.750	0.968
BA vs. AA	Y	15	0.02*	1.422 (1.057–1.915)	0.637	0.088†	0.224	0.760	0.970
BB+BA vs. AA	Y	15	0.013*	1.494 (1.088–2.052)	0.510	0.072†	0.189	0.719	0.963
BB vs. BA+ AA	Y	15	0.009*	1.673 (1.137–2.461)	0.290	0.085†	0.218	0.754	0.969
BA vs. AA	N	3	0.039*	1.335 (1.015–1.757)	0.797	0.129†	0.307	0.830	0.980
rs3804099
BA vs. AA	Overall	9	0.008*	0.827 (0.717–0.952)	0.999	0.024†	0.069†	0.448	0.891
BB+BA vs. AA	Overall	9	0.016*	0.85 (0.744–0.97)	1.000	0.045†	0.125†	0.611	0.941
BB vs. AA	Asian	5	0.005*	0.65 (0.482–0.877)	0.434	0.032†	0.091†	0.524	0.917
BA vs. AA	Asian	5	0.001*	0.69 (0.55–0.867)	0.287	0.064†	0.170†	0.692	0.958
B vs. A	Gastric cancer	2	0.002*	0.728 (0.594–0.893)	0.801	0.009†	0.025†	0.223	0.743
BB vs. AA	Gastric cancer	2	0.026*	0.605 (0.389–0.942)	0.334	0.190†	0.413	0.886	0.987
BA vs. AA	Gastric cancer	2	0.018*	0.706 (0.529–0.942)	0.652	0.076†	0.199†	0.732	0.965
BB+BA vs. AA	Gastric cancer	2	0.004*	0.681 (0.524–0.886)	0.563	0.022†	0.063†	0.426	0.882
BB vs. BA+ AA	Colon cancer	2	0.034*	0.841 (0.716-0.987)	0.998	0.093†	0.235	0.771	0.971
BA vs. AA	HB	4	0.005*	0.713 (0.564–0.902)	0.712	0.020†	0.057†	0.400	0.871
BB+BA vs. AA	HB	4	0.005*	0.734 (0.591–0.912)	0.807	0.019†	0.055†	0.391	0.867
B vs. A	Y	5	0.036*	0.895 (0.807–0.993)	1.000	0.098†	0.247	0.783	0.973
BB+BA vs. AA	Y	5	0.028*	0.844 (0.725–0.982)	0.999	0.078†	0.202	0.736	0.966
BA vs. AA	N	4	0.042*	0.73 (0.54–0.988)	0.722	0.147†	0.341	0.851	0.983
rs3804100
BB vs. BA+ AA	HB	4	0.033*	1.449 (1.031–2.036)	0.579	0.144†	0.336	0.848	0.983
rs4696480
B vs. A	Overall	4	0.03*	1.216 (1.019–1.452)	0.990	0.085†	0.218	0.754	0.969
BB vs. AA	Overall	4	0.032*	1.463 (1.034–2.069)	0.556	0.145†	0.337	0.848	0.983
B vs. A	Caucasian	2	0.007*	1.393 (1.094–1.775)	0.725	0.029†	0.084†	0.501	0.910
BB vs. AA	Caucasian	2	0.009*	1.903 (1.171–3.091)	0.168	0.143†	0.333	0.846	0.982
BA vs. AA	Caucasian	2	0.001*	1.984 (1.307–3.012)	0.095	0.040†	0.110†	0.576	0.932
BB+BA vs. AA	Caucasian	2	0.001*	1.95 (1.317–2.887)	0.095	0.026†	0.075†	0.470	0.899

Statistical power was calculated using the number of observations in the subgroup and the OR and P values in this table. Abbreviations: CI, confidence interval; H-B, hospital based; HWE (Y), polymorphisms conformed to HWE in the control group.

*P-value less than 0.05 was considered as statistically significant.

^†The significant result with the FPRP values less than 0.2 was considered a worthy finding.